Thursday, August 17, 2017 7:25:23 AM
Corix Biosciences, Inc. (OTCQB: CXBS) GW Pharmaceuticals (NASDAQ: GWPH) Should Acquire this Company.
Michael Ogburn, CEO of Corix Bioscience, Inc., stated, "We are very excited about this agreement and expect to generate over $50 million in revenue over the next 12 months as we are currently fielding several calls per day from purchasers of hemp, CBD oil, and raw flower."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM